Article
Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer.
Genetics and molecular research : GMR - 31 Oct 2014
Gao H, Ge R C, Liu H Y, Wang Y, Yan S
Abstract excerpt
We conducted a cohort study to investigate the role of 3 single-nucleotide polymorphisms of the excision repair cross-complementation group 1 (ERCC1) gene on the response to chemotherapy and clinical outcomes of non-small cell lung cancer (NSCLC). A total of 163 patients with newly diagnosed and histopathologically confirmed primary NSCLC were examined in our study and were followed up until December 2012. ERCC1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
